Published in J Rheumatol on November 15, 2013
The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis. Paediatr Drugs (2015) 0.77
Treat to target in the management of chronic uveitis. J Rheumatol (2014) 0.75
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum (2008) 2.27
Ocular changes during pregnancy. Dtsch Arztebl Int (2014) 2.10
Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol (2009) 2.02
Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts. Crit Care (2012) 1.90
Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy. Blood (2011) 1.83
Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell (2008) 1.81
Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry. Clin Res Cardiol (2013) 1.78
Infliximab therapy for refractory uveitis: 2-year results of a prospective trial. Arch Ophthalmol (2009) 1.69
HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol Cell (2006) 1.67
Clinical value of automatic reporting of estimated glomerular filtration rate in geriatrics. Gerontology (2008) 1.54
Malignancy in renal transplantation. J Am Soc Nephrol (2004) 1.50
QuantiFERON TB-Gold--a new test strengthening long-suspected tuberculous involvement in serpiginous-like choroiditis. Am J Ophthalmol (2008) 1.48
Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy. Transpl Int (2012) 1.47
Interferon versus methotrexate in intermediate uveitis with macular edema: results of a randomized controlled clinical trial. Am J Ophthalmol (2013) 1.46
C. elegans as model for the study of high glucose- mediated life span reduction. Diabetes (2009) 1.45
Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients. J Hypertens (2008) 1.42
The influence of haemodialysis on haemodynamic measurements using transpulmonary thermodilution in patients with septic shock: an observational study. Eur J Anaesthesiol (2013) 1.40
Acute phase reaction to gadolinium-DTPA in dialysis patients. Nephrol Dial Transplant (2008) 1.39
Protein dynamics in the nuclear compartment. Curr Opin Genet Dev (2002) 1.37
Intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol (2008) 1.36
Epidemiology and course of disease in childhood uveitis. Ophthalmology (2009) 1.35
Uveitis subtypes in a german interdisciplinary uveitis center--analysis of 1916 patients. J Rheumatol (2009) 1.34
CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS One (2009) 1.34
Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD. Graefes Arch Clin Exp Ophthalmol (2014) 1.28
Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial. Am J Kidney Dis (2011) 1.27
Activation of tubular epithelial cells in diabetic nephropathy. Diabetes (2002) 1.24
Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol (2007) 1.24
Cutoffs and k-mers: implications from a transcriptome study in allopolyploid plants. BMC Genomics (2012) 1.17
Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood (2011) 1.17
Sirolimus in renal transplantation. Nephrol Dial Transplant (2007) 1.15
Disruption of signaling in a fungal-grass symbiosis leads to pathogenesis. Plant Physiol (2010) 1.12
Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc. Proc Natl Acad Sci U S A (2012) 1.11
A subgroup of age-related macular degeneration is associated with mono-allelic sequence variants in the ABCA4 gene. Invest Ophthalmol Vis Sci (2012) 1.10
Antifibrotic actions of mycophenolic acid. Clin Transplant (2006) 1.08
Do AV fistulas contribute to cardiac mortality in hemodialysis patients? Semin Dial (2002) 1.08
Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int (2003) 1.06
Extraction of SSVEP signals of a capacitive EEG helmet for human machine interface. Conf Proc IEEE Eng Med Biol Soc (2008) 1.04
Management of sight-threatening uveitis: new therapeutic options. Drugs (2005) 1.02
Effects of peritoneal dialysis solutions low in GDPs on peritonitis and exit-site infection rates. Perit Dial Int (2008) 1.00
Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol (2009) 1.00
A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum (2005) 1.00
Subnuclear trafficking and gene targeting by steroid receptors. Ann N Y Acad Sci (2004) 1.00
Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care Res (Hoboken) (2012) 0.99
Urochordates and the origin of natural killer cells: identification of a CD94/NKR-P1-related receptor in blood cells of Botryllus. Proc Natl Acad Sci U S A (2003) 0.99
Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization. Can J Ophthalmol (2012) 0.96
Ocular outcome and frequency of neurological manifestations in patients with acute posterior multifocal placoid pigment epitheliopathy (APMPPE). J Ophthalmic Inflamm Infect (2012) 0.96
Oral status in patients with early rheumatoid arthritis: a prospective, case-control study. Rheumatology (Oxford) (2013) 0.95
Pharmacokinetics of linezolid in septic patients with and without extended dialysis. Eur J Clin Pharmacol (2009) 0.92
Myocardial left ventricular dysfunction in patients with systemic lupus erythematosus: new insights from tissue Doppler and strain imaging. J Rheumatol (2009) 0.91
A-RAF kinase functions in ARF6 regulated endocytic membrane traffic. PLoS One (2009) 0.91
Improved learning and memory in aged mice deficient in amyloid beta-degrading neutral endopeptidase. PLoS One (2009) 0.91
Transpalpebral measurement of intraocular pressure using the TGDc-01 tonometer versus standard Goldmann applanation tonometry. Graefes Arch Clin Exp Ophthalmol (2004) 0.90
Cyclosporin A toxicity of the renal allograft--a late complication and potentially reversible. Nephron (2002) 0.90
The Botrytis cinerea Reg1 protein, a putative transcriptional regulator, is required for pathogenicity, conidiogenesis, and the production of secondary metabolites. Mol Plant Microbe Interact (2011) 0.90
Clinical spectrum of tuberculous optic neuropathy. J Ophthalmic Inflamm Infect (2012) 0.90
Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. J Invest Dermatol (2003) 0.90
Aquaporin-1 channel function is positively regulated by protein kinase C. J Biol Chem (2007) 0.89
Glucose degradation products result in cardiovascular toxicity in a rat model of renal failure. Perit Dial Int (2010) 0.89
Replicative aging and differentiation potential of human adipose tissue-derived mesenchymal stromal cells expanded in pooled human or fetal bovine serum. Cytotherapy (2012) 0.89
ABO-incompatible kidney transplantation enabled by non-antigen-specific immunoadsorption. Transplantation (2012) 0.89
Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis. Rheumatology (Oxford) (2009) 0.88
An integrative approach for the transplantation of high-risk sensitized patients. Transplantation (2010) 0.88
H1FOO is coupled to the initiation of oocytic growth. Biol Reprod (2004) 0.88
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma. Br J Ophthalmol (2013) 0.88
Spontaneous dissociation and dislocation of Retisert pellet. Ocul Immunol Inflamm (2013) 0.87
Nanotube action between human mesothelial cells reveals novel aspects of inflammatory responses. PLoS One (2011) 0.87
Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus. Arthritis Rheumatol (2014) 0.86
Salt--a potential 'uremic toxin'? Blood Purif (2006) 0.86
Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-beta peptides. Eur J Pharmacol (2008) 0.86
Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function. Nephrol Dial Transplant (2007) 0.86
Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis. J Am Soc Nephrol (2011) 0.86
Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients. Br J Clin Pharmacol (2010) 0.86
Mesenchymal stromal cells (MSCs): science and f(r)iction. J Mol Med (Berl) (2012) 0.85
Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure. J Am Soc Nephrol (2002) 0.85
RAGE expression in the human peritoneal membrane. Nephrol Dial Transplant (2008) 0.85
Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. Am J Ther (2013) 0.85
C-RAF activation promotes BAD poly-ubiquitylation and turn-over by the proteasome. Biochem Biophys Res Commun (2008) 0.85
Structural substrate conditions required for neutral endopeptidase-mediated natriuretic Peptide degradation. J Mol Biol (2009) 0.85
Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil. Rheumatology (Oxford) (2010) 0.84
Interferons and their potential in the treatment of ocular inflammation. Clin Ophthalmol (2009) 0.84
Progression of age-related geographic atrophy: role of the fellow eye. Invest Ophthalmol Vis Sci (2011) 0.84
How should we manage anaemia in patients with diabetes? Nephrol Dial Transplant (2002) 0.84
Lifestyle modification and progressive renal failure. Nephrology (Carlton) (2005) 0.84
Polycomb protein EED is required for silencing of pluripotency genes upon ESC differentiation. Stem Cell Rev (2015) 0.83
Procalcitonin as marker of infection in patients with Goodpasture's syndrome is misleading. Nephrol Dial Transplant (2007) 0.83
Central angiotensin II controls alcohol consumption via its AT1 receptor. FASEB J (2005) 0.83
Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide. Biol Chem (2004) 0.83
Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort. Mol Vis (2009) 0.83
Interferon therapy for ocular disease. Curr Opin Ophthalmol (2006) 0.83
Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T. Nephron Clin Pract (2007) 0.82
Uremia aggravates left ventricular remodeling after myocardial infarction. Am J Nephrol (2010) 0.82
Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption. Transplantation (2015) 0.82
Identification of small molecule modulators of gene transcription with anticancer activity. ACS Chem Biol (2014) 0.82
Human RAGE antibody protects against AGE-mediated podocyte dysfunction. Nephrol Dial Transplant (2012) 0.81
Time patterns of recurrences and factors predisposing for a higher risk of recurrence of ocular toxoplasmosis. Retina (2015) 0.81